Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) EBIT Margin (2017 - 2025)

Catheter Precision (VTAK) has disclosed EBIT Margin for 9 consecutive years, with 4143.28% as the latest value for Q4 2025.

  • Quarterly EBIT Margin fell 209563.0% to 4143.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2581.56% through Dec 2025, up 9534.0% year-over-year, with the annual reading at 2581.56% for FY2025, 9534.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 4143.28% at Catheter Precision, down from 1336.73% in the prior quarter.
  • The five-year high for EBIT Margin was 720.6% in Q2 2021, with the low at 171750.0% in Q1 2021.
  • Average EBIT Margin over 5 years is 45898.43%, with a median of 3084.18% recorded in 2024.
  • The sharpest move saw EBIT Margin crashed -17118304bps in 2021, then skyrocketed 16262917bps in 2023.
  • Over 5 years, EBIT Margin stood at 165280.0% in 2021, then dropped by -2bps to 169200.0% in 2022, then skyrocketed by 99bps to 2028.91% in 2023, then fell by -1bps to 2047.65% in 2024, then tumbled by -102bps to 4143.28% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 4143.28%, 1336.73%, and 2210.38% for Q4 2025, Q3 2025, and Q2 2025 respectively.